Quantitative Gene Expression of Somatostatin Receptors and Noradrenaline Transporter Underlying Scintigraphic Results in Patients with Neuroendocrine Tumors-Reference-Cited by-同舟云学术

Quantitative Gene Expression of Somatostatin Receptors and Noradrenaline Transporter Underlying Scintigraphic Results in Patients with Neuroendocrine Tumors

Published:2008 Issue:4 Volume:87 Page:223-232
ISSN:1423-0194
Container-title:Neuroendocrinology
language:en
Short-container-title:Neuroendocrinology

Author:

Binderup Tina,Knigge Ulrich,Mellon Mogensen Anne,Palnaes Hansen Carsten,Kjaer Andreas

Publisher

S. Karger AG

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Reference35 articles.

1. Carcinoid A Comprehensive Review

2. Tamoxifen Therapy for Metastatic Carcinoid Tumor: A Negative Study

3. The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors

4. Clinicopathological profile as a basis for classification of the endocrine tumours of the gastroenteropancreatic tract

5. Somatostatin and Other Peptide Receptors as Tools for Tumor Diagnosis and Treatment

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear Medicine Imaging in Neuroendocrine Tumors;Neuroendocrine Tumours;2024

2. Ga-68-Edotreotide Positron Emission Tomography/Computed Tomography Somatostatin Receptors Tumor Volume Predicts Outcome in Patients With Primary Gastroenteropancreatic Neuroendocrine Tumors;Cancer Control;2023-01-30

3. Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study;Annals of Nuclear Medicine;2022-10-30

4. PET-CT in Clinical Adult Oncology—VI. Primary Cutaneous Cancer, Sarcomas and Neuroendocrine Tumors;Cancers;2022-06-08

5. The Potential Prognostic Value of Dual-Imaging PET Parameters Based on 18F-FDG and 18F-OC for Neuroendocrine Neoplasms;Molecular Imaging;2022-03-17